{
    "2021-08-20": [
        [
            {
                "time": "",
                "original_text": "复星医药：投资事项",
                "features": {
                    "keywords": [
                        "复星医药",
                        "投资",
                        "事项"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196.SH)：拟投资以病理免疫组化和肿瘤伴随诊断检测为特色和重点布局方向的苏州百道",
                "features": {
                    "keywords": [
                        "复星医药",
                        "投资",
                        "苏州百道",
                        "病理免疫组化",
                        "肿瘤伴随诊断检测"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "诊断业务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196.SH)子公司拟投资取得苏州百道58.67%股权 完善诊断业务整体布局",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "投资",
                        "苏州百道",
                        "股权",
                        "诊断业务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "诊断业务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "港股跌势扩大：恒生科技指数跌3%，医药股重挫",
                "features": {
                    "keywords": [
                        "港股",
                        "跌势",
                        "恒生科技指数",
                        "医药股",
                        "重挫"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[2196]复星医药中期多赚44.8% 不派息 | 头条金融网",
                "features": {
                    "keywords": [
                        "复星医药",
                        "中期",
                        "盈利",
                        "44.8%",
                        "不派息"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-08-20",
                "original_text": "智通港股通占比异动统计|8月20日",
                "features": {
                    "keywords": [
                        "智通",
                        "港股通",
                        "占比",
                        "异动",
                        "统计"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}